# Efficacy and Safety Study of F373280

> **NCT01831856** · PHASE2 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 135 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** 1g of F373280
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01831856
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2017-04-03
- **Final completion:** 2017-06-21
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831856, "Efficacy and Safety Study of F373280". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01831856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*